Affinity DataKi: 3nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 11.5nM ΔG°: -45.3kJ/molepH: 7.5 T: 2°CAssay Description:The oxidation of NADPH was monitored at 340 nm using a Molecular Devices SpectraMax Plus 96-well microtiter plate reading spectrophotometer. Plots we...More data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 34nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 34nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 72nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 84nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 103nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 108nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 138nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 147nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 171nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 171nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 177nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 188nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 256nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 264nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 291nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 348nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 459nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 600nMAssay Description:Binding affinity to GFP tagged human mGluR2 containing truncated N-terminal region expressed in HEK cells by FRET assayMore data for this Ligand-Target Pair
Affinity DataKi: 800nMAssay Description:Binding affinity to GFP tagged human mGluR2 containing truncated N-terminal region expressed in HEK cells by FRET assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.00E+3nMAssay Description:Binding affinity to GFP tagged human mGluR2 containing truncated N-terminal region expressed in HEK cells by FRET assayMore data for this Ligand-Target Pair
Affinity DataKi: 6.60E+3nMAssay Description:Binding affinity to GFP tagged human mGluR2 containing truncated N-terminal region expressed in HEK cells by FRET assayMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of p38alpha MAP kinase (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.280nMAssay Description:Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of p38alpha MAP kinase (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of p38alpha MAP kinase (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Opioid receptor binding affinity in rat brain membrane preparations by the displacement of [3H]- DPDPE (Opioid receptor delta 1-selective radioligand...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Eberhard-Karls-Universitaet Tuebingen
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of P38 alpha MAPK (unknown origin) by ELISAMore data for this Ligand-Target Pair